2-26456494-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_145038.5(DRC1):c.2200G>A(p.Val734Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0536 in 1,614,084 control chromosomes in the GnomAD database, including 2,640 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_145038.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DRC1 | ENST00000288710.7 | c.2200G>A | p.Val734Met | missense_variant | 17/17 | 2 | NM_145038.5 | ENSP00000288710.2 | ||
DRC1 | ENST00000649059.1 | n.*1163G>A | non_coding_transcript_exon_variant | 16/16 | ENSP00000497543.1 | |||||
DRC1 | ENST00000649059.1 | n.*1163G>A | 3_prime_UTR_variant | 16/16 | ENSP00000497543.1 |
Frequencies
GnomAD3 genomes AF: 0.0419 AC: 6378AN: 152190Hom.: 182 Cov.: 33
GnomAD3 exomes AF: 0.0411 AC: 10326AN: 251352Hom.: 291 AF XY: 0.0423 AC XY: 5753AN XY: 135852
GnomAD4 exome AF: 0.0548 AC: 80152AN: 1461776Hom.: 2458 Cov.: 31 AF XY: 0.0541 AC XY: 39305AN XY: 727196
GnomAD4 genome AF: 0.0418 AC: 6374AN: 152308Hom.: 182 Cov.: 33 AF XY: 0.0395 AC XY: 2943AN XY: 74474
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 09, 2018 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Primary ciliary dyskinesia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at